bms 180448 has been researched along with Hibernation, Myocardial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grover, GJ; Mitroka, JG; Parham, CS; Whigan, DB | 1 |
1 other study(ies) available for bms 180448 and Hibernation, Myocardial
| Article | Year |
|---|---|
BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Dogs; Glyburide; Guanidines; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Potassium Channels; Rats; Rats, Sprague-Dawley | 1996 |